أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

US Equity Indexes Rise as Iran War Expected to End Soon

US equity indexes jumped while crude oil futures fell ahead of Wednesday's close as expectations bui

Canadian Billionaire Rants About Quebec Policies to Analysts in French

Canadian entrepreneur Andrew Lutfy was upbeat after his fast-fashion retailer, Groupe Dynamite Inc., reported excellent results. But before digging into …

3 Reasons WCC is Risky and 1 Stock to Buy Instead

WESCO currently trades at $274.20 and has been a dream stock for shareholders. It’s returned 215% since April 2021, blowing …

Why Beyond Meat Stock Is Plummeting Today

Beyond Meat's latest quarterly report shows the business is still struggling.

‘Death Markets’ and Attack Ads: Prediction Rivalry Turns Nasty

Kalshi Inc. and Polymarket are slinging weighty accusations at each other as the prediction market rivalry heats up and the …

In A Dreadful Month For The Dow Jones Index, One Stock Shined

Chevron is reversing lower, however. It was down 4.5% late Wednesday, on track for its worst decline in almost one …

CFTC Resolves Fraud Case Against Ex-FTX Engineering Chief Singh

Former FTX engineering chief Nishad Singh will have to return $3.7 million in illegal profits under a settlement with the …

‘Boring’ Liberty Formula One Upgraded To Buy at Bank of America

Bank of America Corp. has a message for Liberty Formula One investors as artificial intelligence fears rattle markets in a …

Snap Draws Activist Investor Irenic in Call for Changes

Bloomberg's Ryan Gould joins Dani Burger on "Bloomberg Deals." Activist investor Irenic Capital Management has built a position in social …

Only 1 Sector Is Up Over the Past Month

Energy stocks performed well in March while most other stocks in the S&P 500 were down.

3 Reasons MYRG is Risky and 1 Stock to Buy Instead

MYR Group currently trades at $282.13 and has been a dream stock for shareholders. It’s returned 283% since April 2021, …

Biogen Buys Apellis for $5.6B to Expand Kidney Drugs

Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, expanding …